Cleared Traditional

K240937 - AIM (N/A) (FDA 510(k) Clearance)

Class II Anesthesiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K240937 · Inventeur, LLC · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2024
Decision
255d
Days
Class 2
Risk

K240937 is an FDA 510(k) clearance for the AIM (N/A). Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Inventeur, LLC (Lewes, US). The FDA issued a Cleared decision on December 16, 2024 after a review of 255 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Inventeur, LLC devices

Submission Details

510(k) Number K240937 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 05, 2024
Decision Date December 16, 2024
Days to Decision 255 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
116d slower than avg
Panel avg: 139d · This submission: 255d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Consultant

ProMedic Consulting, LLC
Paul Dryden

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 304
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K240937.
Capnostream™35 Portable Respiratory Monitor (PM35MN)
K253030 · Covidien, LLC · May 2026
Medical Gas Analyzer (AG200)
K250148 · Prior Care Science Technology, Ltd. · Aug 2025
TG-980P CO2 Sensor Kit (TG-980P)
K243956 · Nihon Kohden Corporation · Jun 2025
0184 CO2 Sampling line
K251216 · Barbaras Development, Inc. · Jun 2025
AirLife™ Open Et Oxygen Mask, AirLife™ Open Et+ Oxygen Mask
K230915 · Vyaire Medical, Inc. · Nov 2024
MicroTrend System
K212425 · Exostat Medical, Inc. · Nov 2024